APO Research
Talk to an analyst

APO RESEARCH · REPORT

Disease Control and Prevention Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Disease Control and Prevention Vaccine Industry Research Report 2026

22 December 2025145 pages

Choose your research edition.

Industry ResearchDisease Control and Prevention Vaccine Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Disease Control and Prevention Vaccine Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Disease Control and Prevention Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Disease Control and Prevention Vaccine Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Disease Control and Prevention Vaccine Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Disease Control and Prevention Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Disease Control and Prevention Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Disease Control and Prevention Vaccine market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Disease Control and Prevention Vaccine market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Disease Control and Prevention Vaccine include GSK, Takeda Pharmaceutical Company Limited, Sanofi, Johnson & Johnson, Pfizer, Daiichi Sankyo, AstraZeneca PLC, Sinovac Biotech Ltd and Serum Institute of India Pvt. Ltd, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Disease Control and Prevention Vaccine market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Disease Control and Prevention Vaccine.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Disease Control and Prevention Vaccine Market by Company

GSK

Takeda Pharmaceutical Company Limited

Sanofi

Johnson & Johnson

Pfizer

Daiichi Sankyo

AstraZeneca PLC

Sinovac Biotech Ltd

Serum Institute of India Pvt. Ltd

Panacea Biotec Ltd

Novavax Inc

Mitsubishi Tanabe Pharma Corporation

Merck & Co., Inc

Inovio Pharmaceuticals Inc

Emergent BioSolutions Inc

CSL Limited

Bharat Biotech International

Bavarian Nordic A/S

Astellas Pharma Inc

Abbott Laboratories

Disease Control and Prevention Vaccine Segment by Type

Live-Attenuated

Inactivated

Recombinant Sub Unit and Toxoid

Disease Control and Prevention Vaccine Segment by Application

Pediatric Vaccine

Adult Vaccine

Disease Control and Prevention Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Disease Control and Prevention Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Disease Control and Prevention Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Disease Control and Prevention Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Disease Control and Prevention Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Disease Control and Prevention Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2021-2026) Table 7. Global Disease Control and Prevention Vaccine Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2027-2032) Table 9. Global Disease Control and Prevention Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2021-2026) Table 11. Global Disease Control and Prevention Vaccine Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2027-2032) Table 13. Global Disease Control and Prevention Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Disease Control and Prevention Vaccine Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Disease Control and Prevention Vaccine Market Share by Region (2021-2026) Table 16. Global Disease Control and Prevention Vaccine Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Disease Control and Prevention Vaccine Market Share by Region (2027-2032) Table 18. Disease Control and Prevention Vaccine Industry Trends Table 19. Disease Control and Prevention Vaccine Industry Drivers Table 20. Disease Control and Prevention Vaccine Industry Opportunities and Challenges Table 21. Disease Control and Prevention Vaccine Market Restraints Table 22. Global Top Disease Control and Prevention Vaccine Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Disease Control and Prevention Vaccine Revenue Market Share by Players (2021-2026) Table 24. Global Disease Control and Prevention Vaccine Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Disease Control and Prevention Vaccine, Headquarters and Area Served Table 26. Global Disease Control and Prevention Vaccine Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Disease Control and Prevention Vaccine by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Disease Control and Prevention Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Disease Control and Prevention Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Disease Control and Prevention Vaccine Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Disease Control and Prevention Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Disease Control and Prevention Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Disease Control and Prevention Vaccine Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Disease Control and Prevention Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Disease Control and Prevention Vaccine Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Disease Control and Prevention Vaccine Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Disease Control and Prevention Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Disease Control and Prevention Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Disease Control and Prevention Vaccine Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Disease Control and Prevention Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2027-2032) & (US$ Million) Table 45. GSK Company Information Table 46. GSK Business Overview Table 47. GSK Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 48. GSK Disease Control and Prevention Vaccine Product Portfolio Table 49. GSK Recent Developments Table 50. Takeda Pharmaceutical Company Limited Company Information Table 51. Takeda Pharmaceutical Company Limited Business Overview Table 52. Takeda Pharmaceutical Company Limited Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 53. Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Product Portfolio Table 54. Takeda Pharmaceutical Company Limited Recent Developments Table 55. Sanofi Company Information Table 56. Sanofi Business Overview Table 57. Sanofi Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 58. Sanofi Disease Control and Prevention Vaccine Product Portfolio Table 59. Sanofi Recent Developments Table 60. Johnson & Johnson Company Information Table 61. Johnson & Johnson Business Overview Table 62. Johnson & Johnson Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 63. Johnson & Johnson Disease Control and Prevention Vaccine Product Portfolio Table 64. Johnson & Johnson Recent Developments Table 65. Pfizer Company Information Table 66. Pfizer Business Overview Table 67. Pfizer Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 68. Pfizer Disease Control and Prevention Vaccine Product Portfolio Table 69. Pfizer Recent Developments Table 70. Daiichi Sankyo Company Information Table 71. Daiichi Sankyo Business Overview Table 72. Daiichi Sankyo Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 73. Daiichi Sankyo Disease Control and Prevention Vaccine Product Portfolio Table 74. Daiichi Sankyo Recent Developments Table 75. AstraZeneca PLC Company Information Table 76. AstraZeneca PLC Business Overview Table 77. AstraZeneca PLC Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 78. AstraZeneca PLC Disease Control and Prevention Vaccine Product Portfolio Table 79. AstraZeneca PLC Recent Developments Table 80. Sinovac Biotech Ltd Company Information Table 81. Sinovac Biotech Ltd Business Overview Table 82. Sinovac Biotech Ltd Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 83. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Portfolio Table 84. Sinovac Biotech Ltd Recent Developments Table 85. Serum Institute of India Pvt. Ltd Company Information Table 86. Serum Institute of India Pvt. Ltd Business Overview Table 87. Serum Institute of India Pvt. Ltd Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 88. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Portfolio Table 89. Serum Institute of India Pvt. Ltd Recent Developments Table 90. Panacea Biotec Ltd Company Information Table 91. Panacea Biotec Ltd Business Overview Table 92. Panacea Biotec Ltd Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 93. Panacea Biotec Ltd Disease Control and Prevention Vaccine Product Portfolio Table 94. Panacea Biotec Ltd Recent Developments Table 95. Novavax Inc Company Information Table 96. Novavax Inc Business Overview Table 97. Novavax Inc Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 98. Novavax Inc Disease Control and Prevention Vaccine Product Portfolio Table 99. Novavax Inc Recent Developments Table 100. Mitsubishi Tanabe Pharma Corporation Company Information Table 101. Mitsubishi Tanabe Pharma Corporation Business Overview Table 102. Mitsubishi Tanabe Pharma Corporation Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 103. Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Product Portfolio Table 104. Mitsubishi Tanabe Pharma Corporation Recent Developments Table 105. Merck & Co., Inc Company Information Table 106. Merck & Co., Inc Business Overview Table 107. Merck & Co., Inc Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 108. Merck & Co., Inc Disease Control and Prevention Vaccine Product Portfolio Table 109. Merck & Co., Inc Recent Developments Table 110. Inovio Pharmaceuticals Inc Company Information Table 111. Inovio Pharmaceuticals Inc Business Overview Table 112. Inovio Pharmaceuticals Inc Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 113. Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Product Portfolio Table 114. Inovio Pharmaceuticals Inc Recent Developments Table 115. Emergent BioSolutions Inc Company Information Table 116. Emergent BioSolutions Inc Business Overview Table 117. Emergent BioSolutions Inc Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 118. Emergent BioSolutions Inc Disease Control and Prevention Vaccine Product Portfolio Table 119. Emergent BioSolutions Inc Recent Developments Table 120. CSL Limited Company Information Table 121. CSL Limited Business Overview Table 122. CSL Limited Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 123. CSL Limited Disease Control and Prevention Vaccine Product Portfolio Table 124. CSL Limited Recent Developments Table 125. Bharat Biotech International Company Information Table 126. Bharat Biotech International Business Overview Table 127. Bharat Biotech International Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 128. Bharat Biotech International Disease Control and Prevention Vaccine Product Portfolio Table 129. Bharat Biotech International Recent Developments Table 130. Bavarian Nordic A/S Company Information Table 131. Bavarian Nordic A/S Business Overview Table 132. Bavarian Nordic A/S Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 133. Bavarian Nordic A/S Disease Control and Prevention Vaccine Product Portfolio Table 134. Bavarian Nordic A/S Recent Developments Table 135. Astellas Pharma Inc Company Information Table 136. Astellas Pharma Inc Business Overview Table 137. Astellas Pharma Inc Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 138. Astellas Pharma Inc Disease Control and Prevention Vaccine Product Portfolio Table 139. Astellas Pharma Inc Recent Developments Table 140. Abbott Laboratories Company Information Table 141. Abbott Laboratories Business Overview Table 142. Abbott Laboratories Revenue in Disease Control and Prevention Vaccine Business (2021-2026) & (US$ Million) Table 143. Abbott Laboratories Disease Control and Prevention Vaccine Product Portfolio Table 144. Abbott Laboratories Recent Developments Table 145. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Disease Control and Prevention Vaccine Product Image Figure 5. Global Disease Control and Prevention Vaccine Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Disease Control and Prevention Vaccine Market Share by Type: 2025 VS 2032 Figure 7. Live-Attenuated Product Figure 8. Inactivated Product Figure 9. Recombinant Sub Unit and Toxoid Product Figure 10. Global Disease Control and Prevention Vaccine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Disease Control and Prevention Vaccine Market Share by Application: 2025 VS 2032 Figure 12. Pediatric Vaccine Product Figure 13. Adult Vaccine Product Figure 14. Global Disease Control and Prevention Vaccine Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 15. Global Disease Control and Prevention Vaccine Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Disease Control and Prevention Vaccine Market Share by Region: 2025 VS 2032 Figure 17. Global Disease Control and Prevention Vaccine Market Share by Players in 2025 Figure 18. Global Disease Control and Prevention Vaccine Manufacturers Established Date Figure 19. Global Top 5 and 10 Disease Control and Prevention Vaccine Players Market Share by Revenue in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. North America Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Disease Control and Prevention Vaccine Market Share by Country (2021-2032) Figure 23. United States Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Canada Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Mexico Disease Control and Prevention Vaccine Market Share by Country (2021-2032) Figure 26. Europe Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Europe Disease Control and Prevention Vaccine Market Share by Country (2021-2032) Figure 28. Germany Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. France Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. U.K. Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Italy Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Spain Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Russia Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Netherlands Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Nordic Countries Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Disease Control and Prevention Vaccine Market Share by Country (2021-2032) Figure 38. China Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Japan Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. South Korea Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. India Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Disease Control and Prevention Vaccine Market Share by Country (2021-2032) Figure 43. Australia Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. China Taiwan Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Southeast Asia Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. South America Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Disease Control and Prevention Vaccine Market Share by Country (2021-2032) Figure 48. Brazil Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Argentina Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Chile Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Colombia Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Peru Disease Control and Prevention Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. GSK Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 54. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 55. Sanofi Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 56. Johnson & Johnson Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 57. Pfizer Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 58. Daiichi Sankyo Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 59. AstraZeneca PLC Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 60. Sinovac Biotech Ltd Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 61. Serum Institute of India Pvt. Ltd Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 62. Panacea Biotec Ltd Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 63. Novavax Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 64. Mitsubishi Tanabe Pharma Corporation Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 65. Merck & Co., Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 66. Inovio Pharmaceuticals Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 67. Emergent BioSolutions Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 68. CSL Limited Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 69. Bharat Biotech International Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 70. Bavarian Nordic A/S Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 71. Astellas Pharma Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026) Figure 72. Abbott Laboratories Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2021-2026)

Scope & coverage.

Types
  • Live-Attenuated
  • Inactivated
  • Recombinant Sub Unit and Toxoid
Applications
  • Pediatric Vaccine
  • Adult Vaccine
Companies covered
  • GSK
  • Takeda Pharmaceutical Company Limited
  • Sanofi
  • Johnson & Johnson
  • Pfizer
  • Daiichi Sankyo
  • AstraZeneca PLC
  • Sinovac Biotech Ltd
  • Serum Institute of India Pvt. Ltd
  • Panacea Biotec Ltd
  • Novavax Inc
  • Mitsubishi Tanabe Pharma Corporation
  • Merck & Co., Inc
  • Inovio Pharmaceuticals Inc
  • Emergent BioSolutions Inc
  • CSL Limited
  • Bharat Biotech International
  • Bavarian Nordic A/S
  • Astellas Pharma Inc
  • Abbott Laboratories

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Disease Control and Prevention Vaccine by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Live-Attenuated
  5. 2.2.3 Inactivated
  6. 2.2.4 Recombinant Sub Unit and Toxoid
  7. 2.3 Disease Control and Prevention Vaccine by Application
  8. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  9. 2.3.2 Pediatric Vaccine
  10. 2.3.3 Adult Vaccine
  11. 2.4 Assumptions and Limitations
3 Disease Control and Prevention Vaccine Breakdown Data by Type
  1. 3.1 Global Disease Control and Prevention Vaccine Historic Market Size by Type (2021-2026)
  2. 3.2 Global Disease Control and Prevention Vaccine Forecasted Market Size by Type (2027-2032)
4 Disease Control and Prevention Vaccine Breakdown Data by Application
  1. 4.1 Global Disease Control and Prevention Vaccine Historic Market Size by Application (2021-2026)
  2. 4.2 Global Disease Control and Prevention Vaccine Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Disease Control and Prevention Vaccine Market Perspective (2021-2032)
  2. 5.2 Global Disease Control and Prevention Vaccine Growth Trends by Region
  3. 5.2.1 Global Disease Control and Prevention Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Disease Control and Prevention Vaccine Historic Market Size by Region (2021-2026)
  5. 5.2.3 Disease Control and Prevention Vaccine Forecasted Market Size by Region (2027-2032)
  6. 5.3 Disease Control and Prevention Vaccine Market Dynamics
  7. 5.3.1 Disease Control and Prevention Vaccine Industry Trends
  8. 5.3.2 Disease Control and Prevention Vaccine Market Drivers
  9. 5.3.3 Disease Control and Prevention Vaccine Market Challenges
  10. 5.3.4 Disease Control and Prevention Vaccine Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Disease Control and Prevention Vaccine Players by Revenue
  2. 6.1.1 Global Top Disease Control and Prevention Vaccine Players by Revenue (2021-2026)
  3. 6.1.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Disease Control and Prevention Vaccine Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Disease Control and Prevention Vaccine Head Office and Area Served
  6. 6.4 Global Disease Control and Prevention Vaccine Players, Product Type & Application
  7. 6.5 Global Disease Control and Prevention Vaccine Manufacturers Established Date
  8. 6.6 Global Disease Control and Prevention Vaccine Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Disease Control and Prevention Vaccine Market Size (2021-2032)
  2. 7.2 North America Disease Control and Prevention Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Disease Control and Prevention Vaccine Market Size by Country (2021-2026)
  4. 7.4 North America Disease Control and Prevention Vaccine Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Disease Control and Prevention Vaccine Market Size (2021-2032)
  2. 8.2 Europe Disease Control and Prevention Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Disease Control and Prevention Vaccine Market Size by Country (2021-2026)
  4. 8.4 Europe Disease Control and Prevention Vaccine Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Disease Control and Prevention Vaccine Market Size (2021-2032)
  2. 9.2 Asia-Pacific Disease Control and Prevention Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Disease Control and Prevention Vaccine Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Disease Control and Prevention Vaccine Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Disease Control and Prevention Vaccine Market Size (2021-2032)
  2. 10.2 South America Disease Control and Prevention Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Disease Control and Prevention Vaccine Market Size by Country (2021-2026)
  4. 10.4 South America Disease Control and Prevention Vaccine Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Disease Control and Prevention Vaccine Market Size (2021-2032)
  2. 11.2 Middle East & Africa Disease Control and Prevention Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 GSK
  2. 12.1.1 GSK Company Information
  3. 12.1.2 GSK Business Overview
  4. 12.1.3 GSK Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  5. 12.1.4 GSK Disease Control and Prevention Vaccine Product Portfolio
  6. 12.1.5 GSK Recent Developments
  7. 12.2 Takeda Pharmaceutical Company Limited
  8. 12.2.1 Takeda Pharmaceutical Company Limited Company Information
  9. 12.2.2 Takeda Pharmaceutical Company Limited Business Overview
  10. 12.2.3 Takeda Pharmaceutical Company Limited Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  11. 12.2.4 Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Product Portfolio
  12. 12.2.5 Takeda Pharmaceutical Company Limited Recent Developments
  13. 12.3 Sanofi
  14. 12.3.1 Sanofi Company Information
  15. 12.3.2 Sanofi Business Overview
  16. 12.3.3 Sanofi Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  17. 12.3.4 Sanofi Disease Control and Prevention Vaccine Product Portfolio
  18. 12.3.5 Sanofi Recent Developments
  19. 12.4 Johnson & Johnson
  20. 12.4.1 Johnson & Johnson Company Information
  21. 12.4.2 Johnson & Johnson Business Overview
  22. 12.4.3 Johnson & Johnson Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  23. 12.4.4 Johnson & Johnson Disease Control and Prevention Vaccine Product Portfolio
  24. 12.4.5 Johnson & Johnson Recent Developments
  25. 12.5 Pfizer
  26. 12.5.1 Pfizer Company Information
  27. 12.5.2 Pfizer Business Overview
  28. 12.5.3 Pfizer Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  29. 12.5.4 Pfizer Disease Control and Prevention Vaccine Product Portfolio
  30. 12.5.5 Pfizer Recent Developments
  31. 12.6 Daiichi Sankyo
  32. 12.6.1 Daiichi Sankyo Company Information
  33. 12.6.2 Daiichi Sankyo Business Overview
  34. 12.6.3 Daiichi Sankyo Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  35. 12.6.4 Daiichi Sankyo Disease Control and Prevention Vaccine Product Portfolio
  36. 12.6.5 Daiichi Sankyo Recent Developments
  37. 12.7 AstraZeneca PLC
  38. 12.7.1 AstraZeneca PLC Company Information
  39. 12.7.2 AstraZeneca PLC Business Overview
  40. 12.7.3 AstraZeneca PLC Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  41. 12.7.4 AstraZeneca PLC Disease Control and Prevention Vaccine Product Portfolio
  42. 12.7.5 AstraZeneca PLC Recent Developments
  43. 12.8 Sinovac Biotech Ltd
  44. 12.8.1 Sinovac Biotech Ltd Company Information
  45. 12.8.2 Sinovac Biotech Ltd Business Overview
  46. 12.8.3 Sinovac Biotech Ltd Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  47. 12.8.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Portfolio
  48. 12.8.5 Sinovac Biotech Ltd Recent Developments
  49. 12.9 Serum Institute of India Pvt. Ltd
  50. 12.9.1 Serum Institute of India Pvt. Ltd Company Information
  51. 12.9.2 Serum Institute of India Pvt. Ltd Business Overview
  52. 12.9.3 Serum Institute of India Pvt. Ltd Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  53. 12.9.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Portfolio
  54. 12.9.5 Serum Institute of India Pvt. Ltd Recent Developments
  55. 12.10 Panacea Biotec Ltd
  56. 12.10.1 Panacea Biotec Ltd Company Information
  57. 12.10.2 Panacea Biotec Ltd Business Overview
  58. 12.10.3 Panacea Biotec Ltd Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  59. 12.10.4 Panacea Biotec Ltd Disease Control and Prevention Vaccine Product Portfolio
  60. 12.10.5 Panacea Biotec Ltd Recent Developments
  61. 12.11 Novavax Inc
  62. 12.11.1 Novavax Inc Company Information
  63. 12.11.2 Novavax Inc Business Overview
  64. 12.11.3 Novavax Inc Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  65. 12.11.4 Novavax Inc Disease Control and Prevention Vaccine Product Portfolio
  66. 12.11.5 Novavax Inc Recent Developments
  67. 12.12 Mitsubishi Tanabe Pharma Corporation
  68. 12.12.1 Mitsubishi Tanabe Pharma Corporation Company Information
  69. 12.12.2 Mitsubishi Tanabe Pharma Corporation Business Overview
  70. 12.12.3 Mitsubishi Tanabe Pharma Corporation Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  71. 12.12.4 Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Product Portfolio
  72. 12.12.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
  73. 12.13 Merck & Co., Inc
  74. 12.13.1 Merck & Co., Inc Company Information
  75. 12.13.2 Merck & Co., Inc Business Overview
  76. 12.13.3 Merck & Co., Inc Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  77. 12.13.4 Merck & Co., Inc Disease Control and Prevention Vaccine Product Portfolio
  78. 12.13.5 Merck & Co., Inc Recent Developments
  79. 12.14 Inovio Pharmaceuticals Inc
  80. 12.14.1 Inovio Pharmaceuticals Inc Company Information
  81. 12.14.2 Inovio Pharmaceuticals Inc Business Overview
  82. 12.14.3 Inovio Pharmaceuticals Inc Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  83. 12.14.4 Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Product Portfolio
  84. 12.14.5 Inovio Pharmaceuticals Inc Recent Developments
  85. 12.15 Emergent BioSolutions Inc
  86. 12.15.1 Emergent BioSolutions Inc Company Information
  87. 12.15.2 Emergent BioSolutions Inc Business Overview
  88. 12.15.3 Emergent BioSolutions Inc Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  89. 12.15.4 Emergent BioSolutions Inc Disease Control and Prevention Vaccine Product Portfolio
  90. 12.15.5 Emergent BioSolutions Inc Recent Developments
  91. 12.16 CSL Limited
  92. 12.16.1 CSL Limited Company Information
  93. 12.16.2 CSL Limited Business Overview
  94. 12.16.3 CSL Limited Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  95. 12.16.4 CSL Limited Disease Control and Prevention Vaccine Product Portfolio
  96. 12.16.5 CSL Limited Recent Developments
  97. 12.17 Bharat Biotech International
  98. 12.17.1 Bharat Biotech International Company Information
  99. 12.17.2 Bharat Biotech International Business Overview
  100. 12.17.3 Bharat Biotech International Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  101. 12.17.4 Bharat Biotech International Disease Control and Prevention Vaccine Product Portfolio
  102. 12.17.5 Bharat Biotech International Recent Developments
  103. 12.18 Bavarian Nordic A/S
  104. 12.18.1 Bavarian Nordic A/S Company Information
  105. 12.18.2 Bavarian Nordic A/S Business Overview
  106. 12.18.3 Bavarian Nordic A/S Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  107. 12.18.4 Bavarian Nordic A/S Disease Control and Prevention Vaccine Product Portfolio
  108. 12.18.5 Bavarian Nordic A/S Recent Developments
  109. 12.19 Astellas Pharma Inc
  110. 12.19.1 Astellas Pharma Inc Company Information
  111. 12.19.2 Astellas Pharma Inc Business Overview
  112. 12.19.3 Astellas Pharma Inc Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  113. 12.19.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Product Portfolio
  114. 12.19.5 Astellas Pharma Inc Recent Developments
  115. 12.20 Abbott Laboratories
  116. 12.20.1 Abbott Laboratories Company Information
  117. 12.20.2 Abbott Laboratories Business Overview
  118. 12.20.3 Abbott Laboratories Revenue in Disease Control and Prevention Vaccine Business (2021-2026)
  119. 12.20.4 Abbott Laboratories Disease Control and Prevention Vaccine Product Portfolio
  120. 12.20.5 Abbott Laboratories Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst